ArticleEye (London, England)2025
Early ophthalmological tumour signs and diagnostic interval in children with brain tumours.
Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Visual field defects in children with brain tumors.BMC ophthalmology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChildren with brain tumours often suffer from late diagnosis, impacting cure rates and risk of permanent sequelae. Ophthalmological symptoms are common, and we aimed to investigate the frequency, diagnostic interval, and prognostic value of early-onset ophthalmological brain tumour signs.
methodsThe study is based on data from national Danish health registries and medical files from hospitals and private ophthalmologists collected from all children diagnosed with a primary brain tumour in Denmark during 2007-2017.
resultsAmong 437 included children, 51.7% (n = 226) had ophthalmological tumour signs prior to diagnosis, and 10.8% (n = 47) had ophthalmological symptoms as their initial tumour manifestation. The most common ophthalmological signs in total before diagnosis were reduced visual acuity (n = 73; 16.7%), diplopia (n = 65; 14.9%), abnormal optic nerve (n = 59; 13.5%), and strabismus (n = 50; 11.4%). The median time from initial symptom onset to diagnosis was 12.6 weeks for all children, 15.9 weeks for those with ophthalmological symptoms as their initial tumour sign (p = 0.28), and 12.5 weeks for those with ophthalmological tumour signs at any time before diagnosis (p = 0.71). Children with ophthalmological signs before diagnosis had a higher risk of death (HR: 2.11; 95% CI: 1.32-3.39; p = 0.002).
conclusionsOphthalmological tumour signs are frequent in children with brain tumours, and the diagnostic interval is long regardless of ophthalmological tumour signs being present or not. Taken together with the higher risk of death in the group with ophthalmological tumour signs, this study emphasises the importance of the ophthalmological assessment to ensure timely diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.